Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance - Image 1

£79.54

Wiley Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance

Name: Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance
Brand: Wiley
Price: 80.47 GBP
Availability: InStock

Cardiovascular

Price History & Forecast

Last 33 days • 33 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 33 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £80 (32 days, 97.0%)

Price range: £80 - £80

Price levels: 2 different prices over 33 days

Description

The serious nature of cardiovascular adverse drug reactions occurring in patients makes assessment of a drug's cardiac safety profile a high priority during both development and post-approval monitoring. Integrated Cardiac Safety provides necessary guidance and methodology for professionals assessing cardiac safety of drugs throughout all stages of the drug's life, from discovery and development through postmarketing research. This self-contained, reader-friendly text is valuable to professionals in the pharmaceutical, biotechnology, and CRO industries, pharmacologists, toxicologists, government officials, and students.

Product Specifications

Brand: Wiley
Format: Hardcover
ASIN: 0470229640
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Cardiovascular
Domain: Amazon UK
Release Date: 14 November 2008
Listed Since: 04 July 2007

Barcode

No barcode data available

Wiley Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Drug Safety Evaluation (Pharmaceutical Development Series)

Cardiotoxicity of Non-Cardiovascular Drugs

Evaluation of Drug Candidates for Preclinical Development: Pharmacokinetics, Metabolism, Pharmaceutics, and Toxicology (Wiley Series in Drug Discovery and Development)

Quantitative Drug Safety and Benefit Risk Evaluation: Practical and Cross-Disciplinary Approaches (Chapman & Hall/CRC Biostatistics Series)

Drug-Induced Mitochondrial Dysfunction

Drug-Drug Interactions for Therapeutic Biologics

Pharmacovigilance

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice

Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics

Wiley - Metabolite Safety in Drug Development Reference

Pharmacoepidemiology and Pharmacovigilance: Synergistic Tools to Better Investigate Drug Safety

Antitargets and Drug Safety (Methods & Principles in Medicinal Chemistry)

Humana Drug Safety Evaluation: Methods and Protocols 691

Clinical Trials of Drugs and Biopharmaceuticals

Case Studies in Modern Drug Discovery and Development

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall/CRC Biostatistics Series)

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)

Medical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices

Cardiovascular Pharmacotherapeutics

Advanced Issue Resolution in Safety Pharmacology

Drug Metabolism in Drug Design and Development: Basic Concepts and Practice

Textbook of Interventional Cardiovascular Pharmacology

Pharmaceutical Medicine and Translational Clinical Research

Principles and Practice of Pharmacovigilance and Drug Safety